Consequently, recombinant human TRAIL (RhTRAIL) protein or agonistic antibodies targeting DR4 and DR5, also known as proapoptotic receptor agonists (PARAs), have been developed and found to induce apoptosis of several different cancer cell lines 65. Here, TNFRSF10A is linked to cancer.